Imidazolidine-2,4,5- and pirimidine-2,4,6-triones – new primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.

A series of inhibitors of the soluble epoxide hydrolase (sEH) containing imidazolidine-2,4,5-trione or pirimidine-2,4,6-trione has been synthesized. Inhibition potency of the described compounds ranges from 8.4 μM to 0.4 nM. The tested compounds possess higher water solubility than their preceding u...

Full description

Saved in:
Bibliographic Details
Published in:Bioorg Med Chem Lett
Main Authors: Burmistrov, Vladimir, Morisseau, Christophe, D’yachenko, Vladimir, Karlov, Dmitry, Butov, Gennady M., Hammock, Bruce D.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6957307/
https://ncbi.nlm.nih.gov/pubmed/31870649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2019.126908
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items